Searched for
CNS THERAPEUTIC AREA
For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 33%To get clarity on the markets, there are three questions to which you need answers. First: When will the war end? Second: How long will it ...
- Most difficult: Staying invested in businesses while ignoring noise called Gulf war; 19 stocks from different sectors to ‘hold’Businesses that create long-term wealth are those where the demand runway is long, the competitive position is strong, and the management i...
- Will the currency cycle help them? Yes, but very selectively: 10 pharma stocks with upside potential of up to 33%The biggest mistake made in currency cycles is to confuse revenue gain with pure earnings gain. A company may report stronger rupee revenue...
- Granules unit gets USFDA nod for generic drugGranules India has secured tentative approval from the USFDA for its generic ADHD medication. This approval is for Amphetamine extended-rel...
- Cipla eyes entry into India's weight management market amid rising demand and global competitionCipla is set to enter India's weight management market, addressing the increasing demand for obesity solutions, while also strengthening it...
- Block Deals: Mankind Pharma to see stake sale worth Rs 763 cr; Canada Pension Plan may sell 3.17% in DelhiveryHema CIPEF is selling 37 lakh shares (0.9% of its total equity) at a discounted price of Rs 2,061 per share, 2% below the current market va...
- After a long winter finally some tailwinds; 6 pharma stocks with upside potential of up to 31%While all pharma companies get classified into one sector they are very different at molecular level. Each company has its own operating ma...
- Glenmark Life IPO opens next week; dates, price band announcedAt the higher end of the price band, the company is expected to raise Rs 1,513.6 crore via its initial shale sale. The promoter holds 100 p...
- Cipla seeks favourable policy for domestic pharma cos, ease of doing bizCipla Executive Vice-Chairperson Samina Vaziralli said with the government returning for a second consecutive five-year term armed with a s...
- Eris signs definitive pact to buy Strides’ India portfolio for Rs 500 crThe acquisition is Eris’s fourth and the largest buyout in the last 18 months. With this, the company will be among the top ten companies i...
- ZCL raises Rupees 170 cr from Morgan Stanley PEZCL said it is a speciality pharma company focusing on niche therapeutic areas of central nervous system (CNS), anti-retroviral (ARV) and c...
- Lupin arm buys branded drugs from Japan’s ShionogiThe new branded product portfolio has a strong fit with Lupin’s Kyowa business, as it adds depth and reach to its current CNS (central nerv...
- Aurobindo Pharma gets USFDA nod for Levofloxacin injectionAurobindo Pharma today said it has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Levoflo...
- Jubilant Biosys signs drug discovery pact with Finland's Orion Corporation"The research deal is aimed at developing drug that can benefit large population with unmet needs in the pain management area," Jubilant sa...
- Elder Pharma to enter new therapeutics areas to drive growthThe company plans to further strengthen its in-licence portfolio and increase its presence in CNS therapeutic and cardio-vascular segments.
- Pfizer, Wyeth merger to add more value to stocksIndian units of global drug majors Pfizer and Wyeth have been star performers on Dalal Street, notching up gains of nearly 55% and 60%, res...
- Suven gets patents for 3 NCEs for neuro disorders in IndiaSuven Life Sciences has received product patents in India for three new chemical entities 208688, 208714 and 209540 for treatment of disord...
- Torrent Pharma launches 3 new speciality armsAhmedabad-based Torrent Pharmaceuticals on Friday said it has launched three new speciality divisions to cater to niche therapeutic areas o...
- Suven ties up with US-based pharma coSuven Life Sciences Ltd has signed an agreement with US-based pharmaceutical firm Eli Lilly and Company to carryout pre-clinical research f...
Load More
